OpenAlex
PricingAboutJobs
Log inGet started
Work

Dapagliflozin‐induced weight loss affects 24‐week glycated haemoglobin and blood pressure levels

HTML

Year: 2015
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12500
Authors: C. D. Sjöström, M. Hashemi, J. Sugg, A. Ptaszynska, E. Johnsson
Institutions: AstraZeneca (Sweden), AstraZeneca (United States), Princeton University, Bristol-Myers Squibb (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, SGLT2 inhibitors, weight loss, HbA1c, blood pressure, systolic blood pressure, diastolic blood pressure, type 2 diabetes, antihypertensive effect
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2110067540
FWCI: 5.814
Cites: 13
Cited by: 59
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security